Virtue Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,962
Closed -$2.71M 273
2020
Q3
$2.71M Sell
9,962
-3,695
-27% -$1.01M 0.67% 32
2020
Q2
$3.97M Buy
+13,657
New +$3.97M 0.91% 19
2020
Q1
Sell
-2,079
Closed -$455K 208
2019
Q4
$455K Sell
2,079
-13,241
-86% -$2.9M 0.13% 156
2019
Q3
$2.6M Sell
15,320
-2,168
-12% -$367K 0.86% 38
2019
Q2
$3.21M Buy
+17,488
New +$3.21M 1.17% 22
2018
Q4
Sell
-25,630
Closed -$4.94M 232
2018
Q3
$4.94M Buy
25,630
+15,176
+145% +$2.93M 1.04% 15
2018
Q2
$1.78M Buy
10,454
+4,201
+67% +$714K 0.86% 22
2018
Q1
$992K Buy
6,253
+3,198
+105% +$507K 0.52% 48
2017
Q4
$458K Buy
+3,055
New +$458K 0.26% 106